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http://dx.doi.org/10.1016/j.stemcr.2017.08.020SUMMARYWilms’ tumor suppressor 1 (WT1) plays an important role in cell proliferation and mesenchymal-epithelial balance in normal develop-
ment and disease. Here, we show that following podocyte depletion in three experimental models, and in patients with focal segmental
glomerulosclerosis (FSGS) and membranous nephropathy, WT1 increased significantly in cells of renin lineage (CoRL). In an animal
model of FSGS in RenWt1fl/fl reporter mice with inducible deletion of WT1 in CoRL, CoRL proliferation andmigration to the glomerulus
was reduced, and glomerular disease was worse compared with wild-type mice. To become podocytes, CoRL undergo mesenchymal-to-
epithelial transformation (MET), typified by reduced staining for mesenchymal markers (MYH11, SM22, aSMA) and de novo expression
of epithelial markers (E-cadherin and cytokeratin18). Evidence for changes in MET markers was barely detected in RenWt1fl/fl mice.
Our results show that following podocyte depletion, WT1 plays essential roles in CoRL proliferation and migration toward an adult
podocyte fate.INTRODUCTION
Kidney podocytes are terminally differentiated glomerular
epithelial cells unable to self-renew due to their inability
to proliferate (Lasagni et al., 2013; Wanner et al., 2014),
and replacement following loss is dependent on local kid-
ney progenitors (Ronconi et al., 2009; Lasagni et al.,
2015; Starke et al., 2015). Glomerular parietal epithelial
cells (PECs) (Romagnani, 2011; Zhang et al., 2013; Eng
et al., 2015; Kuppe et al., 2015; Lazzeri and Romagnani,
2015) and cells of renin lineage (CoRL) (Pippin et al.,
2013, 2014; Lichtnekert et al., 2016) are considered likely
adult podocyte progenitors. CoRL serve as progenitors for
several kidney cell types (Sequeira Lopez et al., 2004),
including podocytes (Grahammer et al., 2013; Pippin
et al., 2013, 2014, 2015; Shankland et al., 2014; Lichtnekert
et al., 2016), PECs (Pippin et al., 2013; Eng et al., 2015),
mesangial cells (Thoma, 2014; Starke et al., 2015), and
pericytes (Stefanska et al., 2013; Pippin et al., 2015).
RAAS inhibition augments the CoRL reservoir in the
juxta-glomerular compartment (JGC) through prolifera-
tion, enhances migration to the glomerulus, and increases
transdifferentiation toward a podocyte fate (Lichtnekert
et al., 2016). CoRL and podocytes derive from mesen-
chymal origins (Costantini and Kopan, 2010; Matsushita
et al., 2010; Little and McMahon, 2012; Wang et al.,
2013). CoRL maintain mesenchymal characteristics,
whereas adult podocytes exhibit epithelial characteristics
(Filipovic et al., 2017). Therefore, for CoRL to serve as podo-Stem
This is an open access article under the Ccyte progenitors, they must undergo changes resembling a
mesenchymal-to-epithelial transition (MET).
The transcription factor Wilms’ tumor suppressor pro-
tein 1 (WT1) is required for podocyte development and
homeostasis (Kann et al., 2015). Missense mutations and
conditionally deleting WT1 from podocytes leads to
glomerular scarring in humans and mice (Pelletier et al.,
1991; Gao et al., 2004; Chau et al., 2011). WT1 is closely
linked to the mesenchymal-epithelial balance in develop-
ment and disease (Miller-Hodges and Hohenstein, 2012),
and the homeostasis of different cell types (Ozdemir and
Hohenstein, 2014), including the plasticity and cell fate
of certain cells (Karki et al., 2014; Wen et al., 2016). WT1
drives MET at the start of nephron development (Essafi
et al., 2011; Berry et al., 2015), although in the developing
epicardium, WT1 controls the reverse, i.e., epithelial-to-
mesenchymal transition (Martinez-Estrada et al., 2010).
WT1 enhances proliferation and migration in certain cell
types in a context-dependent manner (Wagner et al.,
2008; Brett et al., 2013; Graziano et al., 2017). Finally,
WT1 and renin co-localize in a fraction of cells in the
afferent arterioles. Moreover, WT1 (KTS) can negatively
modulate renin gene transcription through interaction at
a binding site within the renin enhancer (Steege et al.,
2008).
These reports provided the rationale to test the hypothe-
sis that WT1 is required for CoRL proliferation, migration,
and transdifferentiation toward a podocyte fate in the
context of podocyte depletion.Cell Reports j Vol. 9 j 1–15 j October 10, 2017 j ª 2017 The Author(s). 1
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. WT1 Increases in Renin-Stained
Cells in the Juxta-Glomerular Compart-
ment Following Podocyte Depletion in
the Cytotoxic Anti-podocyte Antibody
Model of FSGS
Confocal microscopy images marked (A–E)
show the merge for WT1 (green), renin
(red), collagen IV (blue), and DAPI (gray).
Collagen IV demarcates glomeruli. Insets
show the JGC for each channel, labeled as
superscripts. Scale bars, 20 mm.
(A) Baseline (n = 5), WT1 (A1) is limited
to podocytes and not detected in renin-
stained cells (A2).
(B) D3 (n = 5), WT1 (B1) is detected in the
cytoplasm of renin-stained cells (B2).
(C) D5 (n = 5), WT1 (C1) increases in
JGC, overlapping with renin (C2), creating a
yellow color.
(D) D14 (n = 5), renin-stained cells (D2) co-
staining with WT1 (D1) increase in the JGC.
(E) D28 (n = 8), WT1 (E1) and renin (E2) co-
staining persists.
(F) Quantitation of the percentage of
renin-stained cells in the JGC co-staining
for WT1.
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WT1 Expression Increases in Renin-Stained Cells
Following Podocyte Depletion in Mice and Humans
We began by measuring the temporal expression of WT1
in renin-stained cells in the JGC in RenWt1+/+ mice
following podocyte depletion induced by the administra-
tion of a cytopathic anti-podocyte antibody. Following
podocyte depletion, the percentage of renin cells co-stain-
ing for WT1 increased as follows (Figures 1A–1F): from a
baseline to D3 of FSGS (6.16% ± 0.3% versus 14.5% ±
3.35%; p = 0.133; Figures 1A and 1B), from baseline to
D5 of FSGS (6.16% ± 0.3% versus 20.99% ± 2.20%;
p = 0.001; Figures 1A and 1C), from D5 to D14
of FSGS (20.99% ± 2.20% versus 33.63% ± 7.3%;
p = 0.001; Figures 1C and 1D), and from baseline to2 Stem Cell Reports j Vol. 9 j 1–15 j October 10, 2017D28 of FSGS (6.16% ± 0.3% versus 26.5% ± 5.24%;
p < 0.0001; Figures 1A and 1E).
Podocyte loss in podocyte TGFb-Receptor1 transgenic
(PodTgfbr1) mice (Figures S1A–S1C) and membranous ne-
phropathy rats (passive Heymann nephritis [PHN] model)
(Figures S1D and S1E) was also accompanied by increased
WT1 in renin-stained JGC cells. In contrast, WT1 was
not detected in renin cells post uninephrectomy in
mice, where absolute podocyte number remained normal
(Figure S1F).
We confirmed the experimental results in human dis-
eases. In normal human kidney, WT1 was mostly limited
to podocytes (Figure 2A). However, de novo WT1 was de-
tected in renin-stained JGC cells in human FSGS (Figure 2B)
and membranous nephropathy (Figure 2C). Similar results
were obtained with different WT1 antibodies, and no
Figure 2. WT1 Increases in Renin-
Stained Cells in the JGC in Human FSGS
and Membranous Nephropathy
Confocal microscopy for WT1, renin, and
DAPI in human kidneys. Insets show the
JGC for each channel: WT1 (1, green), renin
(2, red), DAPI (3, blue), and merged
(4, yellow). Scale bars, 20 mm.
(A) Normal human kidney (n = 5), WT1
is limited to podocytes (A1), and not de-
tected in renin-stained cells (A2), hence no
merge (A4).
(B) Human FSGS (n = 5), WT1 in the JGC
(B1) overlaps with renin-stained cells (B2)
creating a yellow color (B4).
(C) Human membranous nephropathy
(n = 5), WT1 (C1) and renin in the JGC (C2)
produce a yellow color (C4).
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omitted (not shown).
These results show that WT1 protein increases in renin-
stained cells in the JGC in both experimental and human
FSGS and membranous nephropathy in the context of po-
docyte loss.
Selective Deletion of WT1 in Cells of Renin Lineage
HasNo Impact on Podocytes or Kidney Function under
Non-diseased Conditions
To test if de novo expression of WT1 in CoRL has relevance
for their progenitor role to replace lost podocytes, RenCreERtdTomatomice (Pippin et al., 2013, 2015) were crossed with
Wt1fl/fl mice (Martinez-Estrada et al., 2010; DeFilippis and
Wagner, 2014) to generate RenCreER tdTomato Wt1fl/fl
mice (abbreviated RenWt1fl/fl) so that WT1 could be condi-
tionally and selectively deleted in tdTomato-labeled CoRL
(Figure S2). CoRL and their descendants permanently ex-
press tdTomato dependent on Cre-mediated recombina-
tion, which allows lineage tracing of CoRL. Glomerular
cells do not ectopically express renin (and hence Cre) un-
der injury conditions. RenCreER tdTomato Wt1+/+ (abbrevi-
ated RenWt1+/+) served as controls, where tdTomatowas ex-
pressed in CoRL but WT1 remained (Figures S2A, S2F, andStem Cell Reports j Vol. 9 j 1–15 j October 10, 2017 3
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alleles (Figure S2A1), and a flox deletion primer distin-
guished RenWt1fl/fl mice given tamoxifen versus corn oil
(Figure S2A2). Following tamoxifen, Wt1 mRNA from
RFP+CoRL isolated using laser capture microscopy was
significantly lower in RenWt1fl/fl compared with RenWt+/+
mice (Figure S2B), while renin mRNA levels were similar
(Figure S2C). Cre was restricted to the JGC inmice contain-
ing the CreER transgene but not in Cre-negative mice (Fig-
ures S2D and S2E). TdTomato, detected without the use
of an antibody, confirmed similar CoRL labeling efficiency
in RenWt1+/+ and RenWt1fl/flmice given tamoxifen (Figures
S2F and S2G). tdTomato was absent in RenCre-negative
mice (not shown). Ninety-five percent of renin+ CoRL
stained with red fluorescent protein (RFP) antibody, which
detected tdTomato in RenWt1+/+ and RenWt1fl/fl mice (not
shown). Mice that did not report were excluded, account-
ing for <1% of all mice given tamoxifen. At baseline,
WT1 was in a typical podocyte distribution in RenWt1fl/fl
mice, indistinguishable from RenWt1+/+ mice, proving
deletion in CoRL had no impact on podocytes (Figures
S2H and S2I). WT1 was detected in <5% of CoRL in non-
diseased RenWt1+/+ mice but was not detected in CoRL in
non-diseased RenWt1fl/fl mice (Figures S2H and S2I). These
results show thatWt1mRNA and WT1 protein were selec-
tively reduced in tdTomato+ CoRL of RenWt1fl/fl but not in
RenWT+/+mice, with no consequences on podocyte health
under normal conditions.
Increased WT1 Was Not Seen in JGC of Wt1
Conditional Knockout Mice Following Podocyte
Depletion
WT1overlapwith RFP+was not present in the vastmajority
of CoRL in the JGC in normal RenWt1+/+and RenWt1fl/fl
mice (7 ± 2.5 versus 5.6 ± 2.0, respectively; p = 0.99; Figures
3A, 3D, and 3G). In RenWt1+/+ mice at D28 following
podocyte loss, RFP+CoRL in the JGC co-stained with WT1
increased compared with baseline (103 ± 12.36 versus
7 ± 2.5; p < 0.001; Figures 3B and 3G). By contrast, in
RenWt1fl/fl mice at D28, only 5.8 ± 1.8 of RFP+ CoRL in
the JGC co-stained with WT1 (Figures 3E and 3G). Because
enalapril increases RFP+CoRL in the JGC (Lichtnekert et al.,
2016), RenWt1+/+ mice were given enalapril for 25 days
following podocyte loss. RFP+CoRL in the JGC co-express-
ing WT1 further increased at D28 following enalapril
compared with baseline (419.5 ± 117.79 versus 7 ± 2.5;
p < 0.0001; Figures 3A, 3C, and 3G). An increase in WT1
expression was not observed in JGC of RenWt1fl/fl mice af-
ter enalapril (Figures 3F and 3G). Similarly, the number of
RFP+WT1CoRL increased in RenWt1+/+mice following po-
docyte depletion (Figures S3B, S3C), while the number of
RFP+WT1CoRL in RenWt1fl/fl mice did not increase (Fig-
ures S3E, S3F).4 Stem Cell Reports j Vol. 9 j 1–15 j October 10, 2017These results show the following: (1) although WT1 was
not detected in the majority of cells in the JGC under
normal conditions, the number of RFP+CoRL co-expressing
WT1 increases progressively following podocyte loss in
RenWt1+/+ mice; (2) WT1 did not increase in RFP+CoRL in
diseased RenWt1fl/fl mice, consistent with successful tar-
geted ablation of WT1 in CoRL; (3) enalapril increased
the number of CoRL co-expressing WT1 in RenWt1+/+
mice following podocyte loss but not in RenWt1fl/fl mice.
CoRL Migration to the Glomerulus Is Reduced in
RenWt1fl/fl Mice Following Podocyte Depletion
Triple staining was performed for p57 (podocytes), RFP
(tdTomato+, CoRL), and collagen IV (demarcates glomeruli)
to determine if deletingWT1 reducedCoRLmigration from
the JGC to the glomerulus following abrupt podocyte loss.
RFP+CoRL were rarely detected in glomeruli at baseline of
either RenWt1+/+ or RenWt1fl/fl mice (Figures 4A, 4D and
4G). At D28 FSGS in RenWt1+/+ mice, RFP+CoRL were de-
tected in 3.5% ± 2.4% of glomeruli compared with baseline
(0.43% ± 0.2%; p = 0.013; Figures 4B and 4G). At D28 FSGS
in RenWt1fl/fl mice, RFP+CoRL were barely detected in
glomeruli compared with RenWt1+/+ mice (p = 0.001; Fig-
ures 4E and 4G). Consistent with our recent report (Licht-
nekert et al., 2016), administering enalapril to RenWt1+/+
mice following podocyte depletion increased the migra-
tion of RFP+CoRL to 12.95% ± 3.07% of glomeruli
compared with untreated (p < 0.001; Figures 4C and 4G).
However, enalapril had little impact on RFP+CoRL migra-
tion to glomeruli in RenWt1fl/fl mice (Figures 4F and 4G).
Staining for renin and Cre was not detected in glomerular
cells in disease, consistent with CoRL migration to the
glomerulus rather than ectopic renin expression in disease.
These results were similar to our previous reports (Pippin
et al., 2013).
Figures S4 and 4C show that once RFP+CoRL migrated
from the JGC to the glomerulus, a subset de novo co-express
podocyte markers P57 (Figure 4C) podocin (Figure S4A–
S4A4) and synaptopodin (Figure S4B–S4B4), consistent
with CoRL transdifferentiating toward a podocyte fate.
These results show that WT1 is critical for CoRL
migration to the glomerulus following podocyte loss
and their transdifferentiation. In the absence of WT1,
enalapril has reduced efficacy on CoRL migration and
transdifferentiation.
WT1 Is Important for CoRL Proliferation Following
Podocyte Depletion
To test the role of WT1 in CoRL proliferation, bromodeox-
yuridine (BrdU) was administered via intraperitoneal injec-
tions every 48 hr, starting at D2. Triple staining was
performed for BrdU,WT1, and RFP to determine if prolifer-
ation was restricted to RFP+CoRL that co-expressed WT1,
Figure 3. WT1 Does Not Increase in CoRL
in RenWt1fl/fl Mice Following Podocyte
Depletion in the Cytotoxic Anti-
podocyte Antibody Model of FSGS
Confocal microscopy for WT1 (green), RFP
(red), collagen IV (blue), and DAPI (gray)
in FSGS in RenWt1+/+ (A–C) and RenWt1fl/fl
(D–F) mice. Insets show the JGC for each
channel, labeled as superscripts. Scale bars,
20 mm.
(A–C) RenWt1+/+ mice. (A) At baseline WT1
is limited to podocytes (A1); RFP is limited
to the JGC (A2). (B) At D28, WT1 (B1)
merges with RFP (B2) in the JGC, creating a
yellow color. WT1 is reduced in glomeruli.
(C) At D28, after 25 days of enalapril, WT1
(C1) and RFP (C2) are increased in the JGC.
(D–F) RenWt1fl/fl mice. (D) At baseline, WT1
(D1) is limited to podocytes; RFP (D2) is
limited to JGC. (E) At D28, WT1 is reduced in
podocytes, and not detected (E1) in RFP+
cells (E2) in the JGC. (F) At D28, after
25 days of enalapril, there is no WT1(F1) in
RFP+ cells (F2).
(G) Stacked bar graph shows the number
of RFP+CoRL not expressing WT (red) and
co-expressing WT1+ (green) in the JGC.
RFP+WT1+ cells increase progressively in
diseased RenWt1+/+ but not in RenWt1fl/fl
mice (n = 13/group).
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was absent in RFP+CoRL at baseline in RenWt1+/+ and
RenWt1fl/fl mice (Figures 5A, 5D, and 5G). This was not a
false negative, as BrdU was detected in neighboring tu-
bules. Following podocyte depletion in RenWt1+/+ mice,
BrdU increased in RFP+WT1+ cells compared with baseline
(25.8 ± 9.2 versus 0.8 ± 0.5; p < 0.01; Figures 5B and 5G). In
contrast, BrdU was barely detected in RFP+CoRLs in
RenWt1fl/fl mice (Figures 5E and 5G). In enalapril-treated
RenWt1+/+ FSGS mice, RFP+WT1+BrdU+ cells in the JGC
increased compared with untreated mice (131.3 ± 51.7
versus 25.8 ± 9.2; p = 0.0001; Figures 5C and 5G). In enalap-
ril-treated RenWt1fl/fl FSGS mice, RFP+WT1+BrdU+ cells didnot increase (Figures 5F and 5G). To test WT1 independent
proliferation, we counted RFP+BrdU+WT1 cells. BrdU was
only observed in a small portion of RFP+WT1 cells in
RenWt1+/+ FSGS mice compared with baseline (5 ± 0.8
versus 0.3 ± 0.5; p < 0.05; Figures 5B, 5C, and 5G).
Triple staining was also performed for the proliferation
marker Ki67, WT1, and RFP (Figure S7). Ki67 was not
detected in RFP+CoRL at baseline in RenWt1+/+ and
RenWt1fl/fl mice (Figures S7A and S7D) but was detected in
neighboring tubules. Following podocyte depletion, Ki67
increased in RFP+ WT1+CoRL (Figure S7B), which was
augmented by enalapril (Figure S7C). In RenWt1fl/fl mice,
Ki67was barely detected in RFP+CoRL (Figures S7E and S7F).Stem Cell Reports j Vol. 9 j 1–15 j October 10, 2017 5
Figure 4. RFP+CoRL Migration to the
Glomerulus Is Significantly Reduced in
Diseased RenWt1fl/fl Mice Compared
with Diseased RenWt1+/+ Mice
Confocal microscopy for p57 (green, podo-
cytes), RFP (red, CoRL), collagen IV (blue,
demarcates glomerulus), and DAPI (gray,
nucleus). Insets show the glomerulus
marked with a white box, labeled as super-
scripts. Scale bars, 20 mm.
(A–C) RenWt1+/+ mice. (A, A1) In baseline
RenWt1+/+ mice, RFP+CoRL (solid arrows)
are restricted to the JGC and p57 to podo-
cytes. (B, B1) A serial biopsy at D28 in the
same RenWt1+/+ mouse from (A). RFP+CoRL
are in glomeruli (dashed arrows). (C, C1) At
FSGS D28 after enalapril, RFP+CoRL in both
the JGC and glomeruli are further increased
and a subset in the tuft de novo express the
podocyte marker p57 (arrowheads).
(D–F) RenWt1fl/fl mice. (D, D1) In baseline
RenWt1fl/fl mice, RFP+CoRL (solid arrows)
are restricted to the JGC and p57 to podo-
cytes. (E, E1) At D28, despite the decrease
in p57 (podocytes), RFP+CoRL remain
restricted to the JGC (arrow). (F, F1) At D28
after enalapril, RFP+CoRL were mostly
limited to the JGC.
(G) Quantitation of the percentage of
glomeruli with RFP+CoRL increased pro-
gressively in diseased RenWt1+/+ mice but
not in diseased RenWt1fl/fl mice (n = 13/
group).
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following occurs: (1) proliferation (BrdU + or Ki67+) of
CoRL (RFP+) occurs in cells co-expressing WT1; (2) CoRL
proliferation was reduced in RenWt1fl/fl mice; (3) enalapril
increased CoRL proliferation in diseased RenWt1+/+ but
not in RenWt1fl/fl mice.
Following Podocyte Loss, CoRL that Migrate to the
Glomerulus Lose Mesenchymal Markers and De Novo
Acquire Epithelial Markers
CoRL and podocytes derive from mesenchymal lineages
(Boyle et al., 2008; Kobayashi et al., 2008; Costantini
and Kopan, 2010; Little and McMahon, 2012). To deter-
mine if WT1 in CoRL is necessary for changes in mesen-
chymal and epithelial cell markers, and if these changes
were augmented by enalapril, additional studies were per-6 Stem Cell Reports j Vol. 9 j 1–15 j October 10, 2017formed (Figures 6 and S6). Staining for the mesenchymal
marker myosin heavy chain 11 (MYH11) was detected
in 90% ± 7.5% and 84.1% ± 8.2% of RFP+CoRL in the
JGC in baseline RenWt1+/+ and RenWt1fl/fl mice, respec-
tively (Figures 6A, 6D, and 6G). Following podocyte deple-
tion in RenWt1+/+ mice, the percentage of MYH11+RFP+
cells decreased to 67.5% ± 5.3% compared with baseline
(p = 0.0059; Figures 6B and 6G). The percentage of
MYH11+RFP+ cells did not decrease in RenWt1fl/fl mice
with FSGS compared with baseline (82.6% ± 10.6%
versus 84.1% ± 8.2%; p = 0.99; Figures 6E and 6G).
In enalapril-treated FSGS RenWt1+/+ mice, MYH11+
RFP+CoRL decreased (44.3% versus 67.5%; p = 0.008; Fig-
ures 6C and 6G). Giving enalapril to RenWt1fl/fl mice did
not reduce MYH11+RFP+CoRL (78.7% versus 82.6%;
p > 0.99; Figures 6F and 6G). CoRL that migrated to
Figure 5. RFP+CoRL Proliferation Is Significantly Reduced in Diseased RenWt1fl/fl Mice Compared with Diseased RenWt1+/+ Mice
Confocal microscopy for BrdU (blue), WT1 (green), RFP (red), and DAPI (gray) in experimental FSGS in RenWt1+/+ and RenWt1fl/fl mice.
Insets show the JGC for each channel, labeled as superscripts. Scale bars, 20 mm.
(A–C) RenWt1+/+ mice. (A) At baseline, a BrdU+ cell (A1) is detected in the adjacent tubule. BrdU is not detected in the JGC. WT1 (A2) is not
detected in RFP+ cells (A3). (B) At FSGS D28, BrdU (B1) co-localizes with WT1 (B2) and RFP (B3), creating a white/purple color (B5, solid
(legend continued on next page)
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In RFP+CoRL in the JGC, the epithelial cell marker
cytokeratin 18 (CK18) was barely detected at baseline in
either RenWt1+/+ or RenWt1fl/fl mice (Figures 6H, 6K, and
6N). At D28 FSGS in RenWt1+/+ mice, the percentage
of RFP+CK18+CoRL in the JGC increased compared
with baseline (16.8% ± 2.4% versus 1.5% ± 0.9%;
p < 0.0001; Figures 6I and 6N). The percentage of
RFP+CK18+CoRL was further increased by enalapril
compared with baseline (27.25% ± 6.08% versus 16.75% ±
2.36%; p < 0.0001; Figures 6J and 6N). In contrast, in
RenWt1fl/fl mice, the percentage of RFP+CK18+CoRL did
not increase (2.8% ± 3.5% versus 1.5% ± 0.8%; p = 0.606;
Figures 6K, 6L, and 6N), and enalapril had no impact
(3.7% ± 3.1% versus 2.8% ± 3.5% versus FSGS without ena-
lapril; p > 0.99) (Figures 6K, 6M, and 6N).
Figure S6 confirms these results using additional mesen-
chymal and epithelial cell markers. The mesenchymal
markers aSMA (Figures S6A–S6F) and smooth muscle pro-
tein 22 (SM22) (Figures S6G–S6L) were abundant in
RFP+CoRL in the JGC at baseline in both strains (Figures
S6A, S6D, S6G, and S6J). Co-staining for both mesen-
chymal markers decreased in RenWt1+/+ mice with FSGS
(Figures S6B and S6H), and was further decreased by ena-
lapril (Figures S6C and S6I). No RFP+CoRL in glomeruli
co-expressed aSMA or SM22 (Figures 6A and 6C). In
contrast, aSMA+/RFP+CoRL and SM22+/RFP+CoRL did not
decrease in RenWt1fl/fl mice with FSGS, or with enalapril
(Figures S6E, S6F, S6K, and S6L).
The epithelial cell marker E-cadherin was not detected in
RFP+ cells in the JGC at baseline in either RenWt1+/+ or
RenWt1fl/flmice (Figures S6M and S6P). Following podocyte
depletion in RenWt1+/+ mice, RFP+ cells in the JGC de novo
expressed E-cadherin, which was augmented by enalapril
(Figures S6N and S6O). In contrast, E-cadherin staining
was not detected in the JGC in RenWt1fl/fl mice following
podocyte depletion, and enalapril had no effect (Figures
S6Q and S6R).
Following podocyte depletion in RenWt1+/+ mice, a sub-
set of CoRL that migrated from the JGC (Figures S5A1–
S5A4, S5B1–S5B4, and S5C1–S5C4) to the glomerular tuft
no longer expressed aSMA (Figure S5A5–S5A8). There was
de novo expression in CoRL in glomeruli of the epithelial
markers E-cadherin (Figure S5B5–S5B8) and cytokeratinarrows). A few BrdU+ cells do not express WT1 (B1-B5, dashed arrow
increase (C5, solid arrows). A few BrdU+ cells do not express WT1 (C1
(D–F) RenWt1fl/fl mice. (D) At baseline, neither BrdU (D1) nor WT1 (D2
(E1, solid arrow) is detected in the adjacent tubule and does not overl
enalapril, a BrdU+ cell (F1, solid arrow) does not overlap with WT1 (F
(G) Stacked bar graph shows the number of RFP+BrdU+WT1 (blue)
increase progressively in diseased RenWt1+/+ mice but not in RenWt1
8 Stem Cell Reports j Vol. 9 j 1–15 j October 10, 201718 (Figure S5C5–S5C8), coincident with loss of mesen-
chymal markers.
These results show that following abrupt podocyte
depletion, mesenchymal markers (MYH11, aSMA, SM22)
decrease in CoRL, coincident with de novo staining for the
epithelial cell markers cytokeratin 18 and E-cadherin (Fig-
ure S6S). These events were augmented by enalapril in
RenWt1+/+mice, supporting the notion that CoRL undergo
MET in RenWt1+/+ mice with FSGS, but these events are
significantly reduced when WT1 is deleted.Podocyte Replacement Is Lower in Diseased
RenWt1fl/fl Mice
The binding of the podocyte-depleting antibody was
similar in RenWt1+/+ and RenWt1fl/fl mice (Figures S2J and
S2K). Podocyte density, measured by quantitating p57,
was similar at baseline in RenWt1+/+ and RenWt1fl/fl mice
(Figures 7A, 7B, and 7E). Podocyte density decreased in
RenWt1+/+ mice with FSGS compared with baseline
(185.2 ± 17.1 3 106 versus 250.7 ± 10.0 3 106 podocytes/
mm3 glomerular tuft volume; p < 0.0001; Figures 7C and
7E). Moreover, podocyte density was significantly lower
in diseased RenWt1fl/fl mice compared with diseased
RenWt1+/+ mice (109.3 ± 10.09 3 106 versus 185.2 ±
17.1 3 106 podocytes/mm3; p < 0.001; Figures 7D and 7E).
Similar findings were shown for podocin (Figures 7G–
7J). Glomerulosclerosis increased in diseased RenWt1+/+
mice but was significantly higher in diseased RenWt1fl/fl
mice (Figure 7F). The urinary albumin to creatinine ratio
was also significantly higher in diseased RenWt1fl/fl mice
(Figure 7K). In summary, podocyte density was lower in
RenWt1fl/fl mice compared with RenWt1+/+ mice, accompa-
nied by higher glomerulosclerosis and albuminuria.DISCUSSION
Adult podocytes cannot proliferate and are unable to self-
renew following depletion (Barisoni et al., 2000; Paven-
stadt et al., 2003). Their replacement in glomerular diseases
is reliant on progenitors (Romagnani et al., 2013; Shank-
land et al., 2014). CoRL plasticity has been reported in
podocytes, PECs, kidney pericytes, and mesangial cells
(Gomez et al., 2014; Pippin et al., 2015; Starke et al.,
2015; Kaverina et al., 2016; Stefanska et al., 2016). To serve) (C) At D28 after enalapril, BrdU+ (C1), WT1+ (C2), RFP+ (C3) cells
–C5, dashed arrow).
) is detected in RFP+ (D3) cells in the JGC. (E) At D28, a BrdU+ cell
ap with WT1 (E2) or RFP (E3), hence no merge (E5). (F) At D28 after
2) or RFP (F3), hence no merge (F5).
and RFP+BrdU+WT1+ (green) cells in the JGC. RFP+BrdU+WT1+ cells
fl/fl mice (n = 13/group).
(legend on next page)
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number, migrate from the JGC to the glomerulus, and
reprogram from a mesenchymal to an epithelial fate. To
better understand the mechanisms underlying these
events, we selectively genetically deleted WT1 in CoRL in
transgenic mice. Reducing podocytes with a cytopathic
anti-podocyte antibody resulted in a significant reduction
in CoRL proliferation, migration, and MET, suggesting a
critical role for WT1.
We show that WT1 staining is detected in <5%–7% of
renin-expressing cells in the JGC in normal mice and rats,
and only occasionally in the JGC in normal human kid-
neys, similar to previous reports (Puelles et al., 2015). The
first major result of the studies was that following podocyte
depletion in three experimental models, WT1 increased up
to 5.5-fold from baseline in renin-expressing cells in the
JGC.WT1also increased in renin-expressing cells inhuman
FSGS andmembranous nephropathy.WT1did not increase
following uninephrectomy, serving as a negative control
because podocyte number was unchanged.
The role for WT1 is well described in podocyte health
(Ozdemir and Hohenstein, 2014; Mazzei and Manucha,
2016), in non-kidney cell transdifferentiation (Ijpenberg
et al., 2007), and progenitor function (Martinez-Estrada
et al., 2010; Bandiera et al., 2013). To test the hypothesis
that WT1 is necessary for CoRL to function as podocyte
progenitors, we generated a transgenic mouse where WT1
was inducibly deleted specifically in CoRL. Under non-
stressed conditions, deleting WT1 in CoRL had no impact
on kidney or podocyte function and morphology.
CoRL migrate from the JGC to the glomerulus or tubulo-
interstitium during kidney development and in disease
(Sequeira Lopez et al., 2004; Pippin et al., 2013, 2015;
Starke et al., 2015; Zhang et al., 2015; Lichtnekert et al.,
2016). Here, RFP+CoRL were rarely detected in glomeruliFigure 6. RFP+CoRL MET Is Significantly Reduced in Diseased Ren
Confocal microscopy for myosin11 (MYH11, green, mesenchymal marke
show each channel, labeled as superscripts. Scale bars, 20 mm.
(A–C) RenWt1+/+ mice. (A) At baseline, MYH11 (A1) merges with RFP (A
decreases in RFP+ (B2) cells. (C) At D28 after enalapril, MYH11 (C1) d
(D–F) RenWt1fl/fl mice. (D) At baseline, MYH11 (D1) merges with RFP
persists. (F) At D28 after enalapril, MYH11 (F1) in RFP+ cells (F2, soli
(G) The percentage of RFP+CoRL expressing MYH11 decreases in RenWt
show no significant decrease in MYH11 (n = 13/group).
(H–M) Confocal microscopy for cytokeratin 18 (CK18, green, epithelial
Insets show each channel, labeled as superscripts. Scale bars, 20 mm
(H–J) RenWt1+/+ mice. (H) At baseline, CK18 (H1) is barely detected i
(I2), creating a yellow color (solid arrows). (J) At D28 after enalapril, C
(solid arrows).
(K–M) RenWt1fl/fl mice. (K) At baseline, CK18 (K1) is not detected in RF
does not increase in RFP+ cells (L2, M2).
(N) The percentage of RFP+CK18+cells increases in diseased RenWt1+
significantly in diseased RenWt1fl/fl mice (n = 13/group).
10 Stem Cell Reports j Vol. 9 j 1–15 j October 10, 2017of non-diseased RenWt1+/+ and RenWt1fl/fl mice. How-
ever, RFP+CoRL were readily detected in glomeruli in
RenWt1+/+ mice following podocyte depletion, similar to
previous reports (Pippin et al., 2013; Lichtnekert et al.,
2016). The second major finding was that following
podocyte depletion, RFP+CoRL were barely detected in
glomeruli of RenWt1fl/flmice, andmigration to the glomer-
ulus was not augmented by enalapril in RenWt1fl/fl mice.
These results are consistent with WT1 being necessary for
CoRL migration and the enhanced migratory effects of
enalapril. Similar results in the cancer field suggest that
WT1 enhances cell invasion and migration (Jomgeow
et al., 2006; Brett et al., 2013).
CoRL increase in the JGC following podocyte depletion
(Pippin et al., 2013, 2014), increased glomerular volume
(Hodgin et al., 2015), hypotension (Castellanos Rivera
et al., 2011), and following angiotensin-converting
enzyme (ACE) inhibitors and angiotensin receptor blockers
(Lichtnekert et al., 2016). BrdU and Ki67 staining showed
that following podocyte depletion in RenWt1+/+ mice,
RFP+CoRL proliferated, which was augmented by enalapril
(Duim et al., 2015; Lichtnekert et al., 2016). A third
major finding was no increase in CoRL proliferation in
RenWt1fl/flmice, and enalapril had no effect. This was of in-
terest, as several groups have shown that WT1 enhances
proliferation of tumor cells and cardiac endothelial cells
(Li et al., 2015; Wu et al., 2015).
Like podocytes (Boyle et al., 2008; Kobayashi et al.,
2008), CoRL derive from mesenchymal origins (Sequeira
Lopez et al., 2001; Matsushita et al., 2010; Wang et al.,
2013; Ciampi et al., 2016). To become podocytes, CoRL
need to decrease mesenchymal proteins and acquire
epithelial and podocyte proteins. At baseline, RFP+CoRL
in the JGC in both RenWt1+/+ and RenWt1fl/fl mice express
mesenchymal markers (MYH11, aSMA, SM22) but notWt1fl/fl Mice Compared with Diseased RenWt1+/+ Mice
r), RFP (red, CoRL), and DAPI (blue, nuclei) in the JGC (A–F). Insets
2) in the JGC, creating a yellow color. (B) At FSGS D28, MYH11 (B1)
ecreases, despite an increase in RFP+ cells (C2).
(D2). (E) At FSGS D28, MYH11 (E1) in RFP+ cells (E2, solid arrows)
d arrows) also persists.
1+/+ mice with FSGS and is augmented by enalapril. RenWt1fl/fl mice
marker), RFP (red, CoRL), and DAPI (blue, nuclei) in the JGC (H–M).
.
n RFP+ cells (H2). (I) At FSGS D28, CK18 (I1) increases in RFP+ cells
K18 (J1) further increases in RFP+ cells (J2), creating a yellow color
P+ cells (K2). At FSGS D28 (L) and after enalapril (M), CK18 (L1, M1)
/+ mice, which is augmented by enalapril. CK18 does not increase
Figure 7. Podocyte Depletion in the
Cytotoxic Anti-podocyte Antibody Model
of FSGS Is Higher in Diseased RenWt1fl/fl
Mice than in Diseased RenWt1+/+ Mice
(A–F) Podocytes are identified by p57
(brown, nuclear, arrows) and matrix (pink)
in a baseline biopsy from RenWt1+/+ (A) and
RenWt1fl/fl (B) mice, and a serial biopsy in
the same mice at FSGS D28 (C and D). (E)
Podocyte density was similar at baseline but
lower in diseased RenWt1fl/fl compared with
diseased RenWt1+l+ mice. (F) Glomerulo-
sclerosis is higher in diseased RenWt1fl/fl
compared with diseased RenWt1+/+ mice.
(G–J) Podocin staining (green) is similar in
healthy podocytes in baseline RenWt1+/+
(G) and RenWt1fl/fl (H) mice. Podocin de-
creases at FSGS D28 in RenWt1+/+ mice (I)
and is more pronounced in diseased
RenWt1fl/fl mice (J). Scale bars, 20 mm.
(K) Urinary albumin to creatinine ratio in
RenWt1fl/fl mice (dark bars) is higher than
RenWt1+/+ mice (light bars) (n = 13/group).
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podocyte depletion in RenWt1+/+ mice, RFP+CoRL in the
JGC expressing these mesenchymal markers decreased
significantly. This coincided with the de novo expression
of cytokeratin 18 and E-cadherin. The MET-like changes
in diseased RenWt1+/+ mice were augmented by enalapril.
When in the glomerulus, a subset of CoRL co-expressed
the podocyte markers p57, podocin, and synaptopodin.
The fourth major finding was that following podocyte
depletion in RenWt1fl/fl mice, mesenchymal markers in
RFP+ CoRL did not decrease, nor did they begin to express
epithelial markers, and enalapril had no impact.
These findings are consistent with our previous reports
on the importance of disruption of MET underlying the
origin of Wilms’ tumors (Berry et al., 2015; Hohenstein
et al., 2015), the role ofWt1 in this MET programming (Da-vies et al., 2004; Essafi et al., 2011), and that loss of WT1
blocks MET in the cap mesenchyme (Essafi et al., 2011).
The fifth major finding was that following abrupt podo-
cyte loss, podocyte density remained lower in diseased
RenWt1fl/fl compared with diseased RenWt1+/+mice, accom-
panied by more glomerular scarring and albuminuria. We
recognize that CoRL transdifferentiation alone is not
sufficient to explain the differences, and other factors
including different kidney progenitor populations need
to be considered.
Finally, our observation of intra-glomerular CoRL
with coincident downregulation of renin expressionwould
be consistent with the negative regulation previously
described (Steege et al., 2008). It will be of interest to assess
the specific isoform(s) of WT1 expressed and retained in
CoRL and the kinetics of renin downregulation and otherStem Cell Reports j Vol. 9 j 1–15 j October 10, 2017 11
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In summary, WT1 expression in CoRL is important for
the glomerular response to damage. When WT1 is selec-
tively deleted in CoRL in the setting of podocyte loss, their
proliferation andmigration to the glomerulus, and to some
extent their transdifferentiation toward a podocyte fate
through MET changes, are markedly reduced.EXPERIMENTAL PROCEDURES
RenCreER tdTomato Wt1+/+andWt1fl/fl Reporter Mice
Ren1cCreERxRs-tdTomato-R mice (Pippin et al., 2013) were crossed
with a Wt1 conditional knockout mouse (Wt1fl/fl) (Martinez-
Estrada et al., 2010). Wt1 was inactivated in RenCreER tdTomato
Wt1fl/fl mice (abbreviated RenWt1 fl/fl) by administration of
100 mg/kg tamoxifen on four occasions. Mouse genotype was
identified by PCR (Martinez-Estrada et al., 2010). Kidney biopsies
were performed to assess CoRL labeling as described in Supple-
mental Experimental Procedures. RenWt1fl/fl and RenWt1+/+ were
housed in the animal care facility of the University of Wash-
ington (UW) under specific pathogen-free conditions with food
and water available ad libitum. These studies were reviewed
and approved by the UW Institutional Animal Care and Use
Committee (2968-04).Experimental Models of Glomerular Disease
Accompanied by Podocyte Depletion
The following experimental models of podocyte depletion were
used:
(1) A cytotoxic sheep anti-glomerular antibody model of
experimental FSGS was induced in RenWt1fl/f and
RenWt1+/+mice as previously described (Kaverina et al.,
2016; Lichtnekert et al., 2016). On D3, when podocyte
number was decreased by 30%–40%, mice were random-
ized into two groups: group 1 received drinking water;
group 2 received the ACE inhibitor enalapril (75 mg/mL).
Mice were killed on D28. Urine was collected at baseline,
and on days 7, 14, and 28. Amersham Cell Proliferation
Labeling Reagent (GE Healthcare Life Sciences, Little
Chalfont, UK) was administered to quantitate cell prolifer-
ation (Kaverina et al., 2016). Urines were collected
for albumin measurements by radial immunodiffusion
assay (RID) (Marshall et al., 2011); urine creatinine was
measured by colorimetric micro-plate assay (Cayman
Chemical Company, Ann Arbor, MI).
(2) Podocyte TGFb-Receptor1 transgenic (PodTgfbr1) mice
given doxycycline underwent TGFbR1-induced podocyte
apoptosis and loss of 25% (D7) and 40% (D14), accompa-
nied by glomerulosclerosis (Daehn et al., 2014).
(3) A PHNmodel ofmembranous nephropathy induced as pre-
viously described (Ohse et al., 2010) underwent progressive
podocyte depletion (Petermann et al., 2003).
(4) A uninephrectomy model served as a negative control for
podocyte depletion (Pippin et al., 2015).12 Stem Cell Reports j Vol. 9 j 1–15 j October 10, 2017Human Glomerular Disease
Kidney biopsies from patients with FSGS and membranous ne-
phropathy were obtained from the University of Chicago (UC).
The study protocol was approved by the UC Institutional Review
Board. Further details are described in Supplemental Experimental
Procedures.
Laser Capture Microscopy and qRT-PCR
RFP+CoRL were isolated by LCM, as described (Tretiakova and Hart,
2011), with the Leica Laser Microdissection Systems LMD6500 and
LMD7000 (Leica Microsystems Inc., Buffalo Grove, IL).
Immunoperoxidase and Immunofluorescent Staining
Formalin-fixed paraffin-embedded mouse, rat, and human kidney
sections or frozen tissue sections (4–20 mm thick) were used.
Following standard antigen retrieval steps, Avidin-biotin based,
polymer-based, and fluorochrome-based staining was performed
as previously described (Kimura et al., 1995; Wagner et al., 2014).
Further details are described in Supplemental Experimental
Procedures.
Quantitative Analysis
Absolute numbers of renin+, RFP+, WT1+, and RFP+/WT1+ ex-
pressing cells were counted in the JGC of fluorescence-stained
sections. Results were expressed as a percentage of co-localized
RFP+/WT1+ cells per number of renin+ cells. The percentage of
proliferating (BrdU+) CoRL co-expressing WT1 in the JGC was
measured by dividing the number of RFP+/WT1+/BrdU+-stained
cells by the total number of RFP+ cells in the JGC. The total num-
ber of glomeruli and glomeruli with RFP+ cells were counted to
determine the percentage of glomeruli with RFP+ cells. Absolute
numbers of RFP+-, MYH11+, CK18+, MYH11+/RFP+, and CK18+/
RFP+-expressing cells were counted in the JGC. Results were ex-
pressed as a percentage of MYH11+/RFP+ and CK18+/RFP+ cells
per number of RFP+ cells in the JGC. Podocyte number was
measured on 150 ± 20 glomeruli per animal on p57/periodic
acid-Schiff-stained sections (Zhang et al., 2015; Lichtnekert
et al., 2016).
Statistical Analysis
Groups were compared using a one-way or two-way ANOVA for
multiple comparisons with Bonferroni post hoc analysis with sig-
nificant set at p < 0.05. Data are presented as means ± SEM. All
data were analyzed in GraphPad Prism 5.0 (GraphPad Software,
La Jolla, CA).SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and seven figures and can be found with this article
online at http://dx.doi.org/10.1016/j.stemcr.2017.08.020.
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